The IL-9−/− PCP mice had increased Pneumocystis burden in lung while receiving IL-17A neutralization, providing the evidence to establish the association of enhanced Th17 responses and weak Pneumocystis burden. The gene discussed is IL9; the disease is pneumocystosis.